Citations

Showing 10 of 108152 citations.

Association of Characteristics of the Learning Environment and US Medical Student Burnout, Empathy, and Career Regret
Satele, Daniel , Dyrbye, Liselotte N. , West, Colin P.

Mayo Clinic

JAMA Network Open | August 9, 2021 | Volume: 4 | Issue: 8 | Pages: e2119110

10.1001/jamanetworkopen.2021.19110 | PMID 34369990 Get It

Past, present, and future of mortality risk scores in the contemporary cardiac intensive care unit
Jentzer, Jacob C. , Rosselló, Xavier , Jentzer, Jacob C

Mayo Clinic

European Heart Journal. Acute Cardiovascular Care | August 9, 2021 | Volume: 10 | Issue: 8 | Pages: 940-946

10.1093/ehjacc/zuab072 | PMID 34453848 Get It

AbstractRisk stratification dates to the dawn of the cardiac intensive care unit (CICU). As the CICU has evolved from a dedicated unit caring for patients with acute myocardial infarction to a complex healthcare environment encompassing a broad array of acute and chronic cardiovascular pathology, an expanding array of risk scores are available that can be applied to CICU patients. Most of these scores were designed for use either in patients with a specific acute cardiovascular diagnosis or unselected critically ill patients, and risk scores developed in other populations often underperform in the CICU. More recently, risk scores have been developed specific to the CICU population, demonstrating improved performance. All existing risk scores have relevant limitations, both in terms of performance and applicability to patient care. Risk scores have been predominantly developed to predict short-term mortality, either by quantifying severity of illness or by incorporating other risk factors for mortality. It is essential to distinguish mortality risk attributable to severity of illness, which may be modifiable through intervention, from mortality risk attributable to non-modifiable risk factors. This review discusses established risk scores applicable to the CICU population, details how risk score performance is characterized, describes how new risk scores can be developed, explains how the information provided by risk scores can be used in clinical practice, and highlights how novel risk stratification approaches can be developed.
Deciphering the interactions of SARS-CoV-2 proteins with human ion channels using machine learning-based method
Munjal, Nupur S., Sapra, Dikscha , Goyal, Abhishek , Parthasarathi, Kaushik , Pandey, Akhilesh , Banerjee, Manidipa , Sharma, Jyoti , Pandey, Akhilesh , Parthasarathi, K.T. Shreya

Mayo Clinic

No container title available | August 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-622770/v2 Get It

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the worldwide COVID-19 pandemic which began in 2019. It has a high transmission rate and pathogenicity leading to health emergencies and economic crisis. Recent studies pertaining to the understanding of the molecular pathogenesis of SARS-CoV-2 infection exhibited the indispensable role of ion channels in viral infection inside the host. Moreover, machine learning (ML)-based algorithms are providing higher accuracy for host-SARS-CoV-2 protein-protein interactions (PPIs). In this study, predictions of PPIs of SARS-CoV-2 proteins with human ion channels (HICs) were performed using PPI-MetaGO algorithm. The PPIs were predicted with 82.71% accuracy, 84.09% precision, 84.09% sensitivity, 0.89 AUC-ROC, 65.17% Matthews correlation coefficient (MCC) score and 84.09% F1 score. Thereafter, PPI networks of SARSCoV-2 proteins with HICs were generated. Furthermore, biological pathway analysis of HICs interacting with SARS-CoV-2 proteins showed the involvement of six pathways, namely inflammatory mediator regulation of transient receptor potential (TRP) channels, insulin secretion, renin secretion, gap junction, taste transduction and apelin signaling pathway. Our analysis suggests that transient receptor potential cation channel subfamily M member 4 (TRPM4), transient receptor potential cation channel subfamily A member 1 (TRPA1), gap junction protein alpha 1 (GJA1), potassium calcium-activated channel subfamily N member 4 (KCNN4), acid sensing ion channel subunit 1 (ASIC1) and inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) could serve as an initial set to the experimentalists for further validation. Additionally, various US food and drug administration (FDA) approved drugs interacting with the potential HICs were also identified. The study also reinforcesthe drug repurposing approach for the development of host directed antiviral drugs.
FD-895 and Pladienolide B Modulate RNA Splicing Associated With Wnt Signaling Pathway
Spaanderman, Ide , Villa, Reymundo, Castro, Januario E. , Kumar, Deepak , Kashyap, Manoj Kumar , Yu, Zhe , Kipps, Thomas J. , Clair, James J. La , Burkart, Michael D.

Mayo Clinic

No container title available | August 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-768225/v1 Get It

Abstract BackgroundAlterations in RNA splicing are associated with different malignancies including leukemia, lymphoma, and solid tumors. The RNA splicing modulators such as FD-895 and pladienolide B have been investigated in different malignancies to target/modulate spliceosome for therapeutic purpose. MethodsThe different cell lines were screened using RNA splicing modulator to test in vitro cytotoxicity as well as ability to modulate RNA splicing capability via induction of intron retention (using RT-PCR and qPCR) was assessed. The Cignal Finder Reporter Array was used to screen the HeLa cell line to know the pathway affected the most by the splice modulators. Further the candidates associated with the pathways were validated at protein levels using western blot assay and gene-gene interaction study were carried out using GeneMANIA.ResultsWe show that FD-895 and pladienolide B have more apoptotic activities than conventional chemotherapy in different solid tumors. We found FD-895 or pladienolide B modulate Wnt signaling pathways and mRNA splicing. We showed that FD-895 or pladienolide B significantly down regulates not only Wnt signaling pathway-associated transcripts (GSK3β and LRP5), but also both transcript and proteins including LEF1, CCND1, LRP6, and pLRP6. ConclusionThese results indicate FD-895 and pladienolide B inhibit Wnt signaling by impeding with phosphorylation of LRP6 and modulates mRNA splicing through induction of intron retention in cervical cancer cells.
Osteoclast-Like Giant Cell Tumors of the Pancreas
Ueberroth, Benjamin E. , Liu, Alex J. , Graham, Rondell P. , Bekaii‐Saab, Tanios , Truty, Mark J. , Mody, Kabir , Sonbol, M Bassam, Graham, Rondell P , Bekaii-Saab, Tanios S , McWilliams, Robert R. , Mahipal, Amit , Sonbol, Mohamad Bassam , Hálfdánarson, Þorvarður R.

Mayo Clinic

Pancreas | August 9, 2021 | Volume: 50 | Issue: 7 | Pages: 952-956

10.1097/mpa.0000000000001858 | PMID 34369897 Get It

Objectives This study sought to better characterize patient characteristics, treatment options, and outcomes for osteoclast-like giant cell carcinoma of the pancreas, a rare subtype of pancreatic adenocarcinoma. Methods This is a retrospective study of all patients with osteoclast-like giant cell carcinoma of pancreatic origin treated at Mayo Clinic from 2000 to present. Baseline patient characteristics, treatment modalities utilized, and outcomes were compiled. Overall survival (OS) and progression-free survival were assessed using Kaplan-Meier analysis with a significance level of P ≤ 0.05. Results Fifteen patients met criteria for inclusion. Four patients had distant metastases at diagnosis, the remaining 11 with locoregional disease. Median OS for the entire cohort was 11 months. Metastatic disease was associated with significantly shorter OS (3.5 vs 14.1 months; P = 0.005). Three patients had no evidence of disease at time of analysis; all 3 were treated with complete resection followed by adjuvant chemotherapy. Conclusions Osteoclast-like giant cell carcinoma of the pancreas is an aggressive malignancy with poor prognosis. For patients with locoregional disease, surgical resection followed by adjuvant chemoradiation may play a role in extended disease-free survival. Metastatic disease presents a challenging entity to treat with little data to support any effective chemotherapy regimens.
Improving digital charge sharing compensation in photon counting detectors with a low‐threshold comparator
Hsieh, Scott S. , Iniewski, Kris, Hsieh, Scott Sigao

Mayo Clinic

Medical Physics | August 9, 2021 | Volume: 48 | Issue: 10 | Pages: 5819-5829

10.1002/mp.15154 | PMID 34370321 Get It

AbstractPurposeCharge sharing is a major non‐ideality in photon counting detectors (PCDs) and can increase variance in material decomposition images. Analog charge summing (ACS) is an effective mechanism for charge sharing compensation (CSC), but is complex to implement and may limit the maximum count rate of the PCD. Digital CSC mechanisms such as digital count summing (DCS) may be simpler to implement; however, earlier simulation studies suggest that digital CSC only provides half the benefit of ACS. We propose including an additional low‐threshold comparator (LTC) underneath the noise floor of the PCD to improve the effectiveness of digital CSC.MethodsWe simulated a PCD with four or eight equally spaced energy bins. X‐ray photons arrived on the PCD following a Poisson distribution, and charge was allocated to PCD pixels following Monte Carlo techniques. Gaussian electronic noise was added with standard deviation of 2 keV and the signals were processed with four CSC schemes: no CSC, ACS, DCS, and DCS with LTC. The energy bins were placed from 25 to 100 keV at 25 keV intervals (for four bins) or from 25 to 112.5 keV at 12.5 keV intervals (for eight bins), and the LTC threshold was placed at 8 keV in both cases. The binned counts were transformed into estimates of water and iodine material thickness using a linear estimator that was fitted to the data. Our simulations were performed in the low‐flux limit without any pileup, assuming a 120 kVp spectrum, 25 cm water object, and 0.3 mm PCD pixel size.ResultsAll CSC schemes decreased variance in basis material decomposition. In the four‐bin PCD, the relative dose efficiencies (inverse of the variance) for iodine material decomposition were 1.0, 2.4, 3.2, and 4.3 for a PCD without CSC, DCS without LTC, DCS with LTC, and ACS, respectively. In the eight‐bin PCD, the relative dose efficiencies were 1.1, 2.5, 3.1, and 4.8, respectively. In a sensitivity analysis, electronic noise had a stronger deleterious effect on ACS than DCS. In simulated visual images, DCS and ACS improved high frequency contrast in material decomposition images.ConclusionsIntroducing an LTC may reduce the performance differential between DCS and ACS. These findings have been derived from simulation studies only and have not been validated experimentally.
Letter: Predictors of Academic Neurosurgical Career Trajectory Among International Medical Graduates Training Within the United States
Ozair, Ahmad , Negida, Ahmed , Ghaith, Abdul Karim , Kanmounye, Ulrick Sidney , Kanmounye, Ulrick Sidney , Ghaith, Abdul Karim , Ozair, Ahmad , Negida, Ahmed

Mayo Clinic

Neurosurgery | August 9, 2021 | Volume: 89 | Issue: 6 | Pages: E338-E339

10.1093/neuros/nyab328 | PMID 34423822 Get It

Aneurysmal bone cyst with an unusual clinical presentation and a novel VDR‐USP6 fusion
Papke, David , Bredella, Miriam A. , Lozano‐Calderón, Santiago A. , Oliveira, André M. , Lennerz, Jochen K. , Nielsen, G. Petur , Papke, David J , Lennerz, Jochen

Mayo Clinic

Genes, Chromosomes and Cancer | August 9, 2021 | Volume: 60 | Issue: 12 | Pages: 833-836

10.1002/gcc.22989 | PMID 34369017 Get It

AbstractAneurysmal bone cyst is a benign bone neoplasm that most commonly arises from the metaphyses of long bones in the first and second decades of life. Here, we describe a case of an aneurysmal bone cyst that occurred in the distal tibial diaphysis of a 72‐year‐old female that was concerning for malignancy on imaging, demonstrating cortical breakthrough and soft tissue extension. Histologically, the tumor showed the characteristic morphologic features of aneurysmal bone cyst. Fluorescence in situ hybridization was positive for USP6 rearrangement, and RNA sequencing revealed a USP6 gene fusion with VDR, a novel partner that encodes the vitamin D receptor and that has not been implicated previously in human neoplasia. This case highlights the diagnostic challenges presented by aneurysmal bone cyst in elderly adults, and it expands the genetic spectrum of USP6 rearrangements.
Commentary on Blood Perfusion of Random Skin Flaps in Humans—In Vivo Assessment By Laser Speckle Contrast Imaging
Brewer, Jerry D.

Mayo Clinic

Dermatologic Surgery | August 9, 2021 | Volume: 47 | Issue: 11 | Pages: 1427-1427

10.1097/dss.0000000000003187 | PMID 34366404 Get It

Distribution of rare LOXL1 missense alleles, haplotypes, and diplotypes suggests association with reduced risk of glaucoma-related exfoliation syndrome
Aboobakar, Inas F., Igo, Rob P., Kinzy, Tyler G., Bailey, Jessica N. Cooke, Khor, Chiea Chuen, Aung, Tin, Ritch, Robert, Sit, Arthur J., Lee, Richard K., Pericak-Vance, Margaret, Kang, Jae H., Haines, Jonathan L., Pasquale, Louis R., Wiggs, Janey L. , Bailey, Jessica N. Cooke , Pasquale, Louis R. , Aung, Tin , Aboobakar, Inas F., Igo, Rob P., Kinzy, Tyler G., Bailey, Jessica N. Cooke, Khor, Chiea Chuen, Aung, Tin, Ritch, Robert, Sit, Arthur J., Lee, Richard K., Pericak-Vance, Margaret, Kang, Jae H., Haines, Jonathan L.

Mayo Clinic

No container title available | August 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2021.08.05.21261676 Get It

ABSTRACT/SUMMARY Purpose Common LOXL1 protein-altering variants are significant genetic risk factors for exfoliation syndrome (XFS) and the related secondary glaucoma (XFG). A rare LOXL1 missense allele was associated with protective effects in a Japanese cohort, suggesting that other rare alleles may also exhibit protective effects. The goal of this study is to assess the contributions of rare LOXL1 variants to XFS/XFG risk in cases and controls from the United States (US). Methods LOXL1 rare variants (minor allele frequency (MAF) < 1%) were identified from Human exome BeadArray (Illumina) data for 1118 XFS/XFG cases and 3661 controls (Mass Eye and Ear (MEE) cohort) and from exome sequence data for 284 cases and 37,499 controls in All of Us (AoU) The distribution of rare variants, haplotypes, and diplotypes was examined using Fisher exact test. Results Four rare LOXL1 missense alleles, more common in controls, were identified in MEE, P= 7.6E-4), and 456 variants identified in AoU were found only in controls (P=0.045). The rare protective alleles were preferentially located (P= 5.8E-45) in a LOXL1 intrinsic disordered region (IDR) potentially involved in LOXL1 aggregation. Haplotypes that included the rare or minor variants were more common in controls compared to cases in both MEE (Odds Ratio (OR)= 0.21 (95% Confidence interval (CI): 0.19-0.24), P=1.7E-173) and AoU (OR=0.28 (95% CI: 0.23-0.34), P=4.4E-41), and heterozygous diplotypes were also significantly associated with reduced risk overall in both MEE (OR= 0.45 (95% CI: 0.52-0.39), P= 1.7E-89) and AoU (OR=0.26 (95% CI: 0.18-0.33, P=7.6E-28). Diplotypes comprised of only homozygous genotypes were associated with increased disease risk in both MEE and AoU (OR= 4.16 (95% CI: 3.60-4.76), P= 4.2E-89 and 5.26 (95% CI: 4.12-6.73), P=1.87E-42, respectively) and excess homozygosity and decreased heterozygosity was correlated with disease risk for common LOXL1 variants across multi-ethnic populations (P=1.0E-6). Conclusions Using exome array and exome sequence data from XFS/XFG cases and controls from the United States, we identified rare protective LOXL1 missense variants and show that the distribution of the corresponding haplotypes and diplotypes was associated with lower risk of XFS/XFG. Diplotype results also demonstrated that LOXL1 allelic heterozygosity was inversely associated, while homozygosity was associated with increased disease risk. These results suggest that LOXL1 MAF variation among populations, with corresponding variation in genotype heterozygosity and homozygosity, determines the XFS/XFG association.